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Abstract: NCAPG is a subunit of condensin I that plays a crucial role in chromatin condensation
during mitosis. NCAPG has been demonstrated to be associated with farm animal growth traits.
However, its role in regulating myoblast differentiation is still unclear. We used myoblasts derived
from fetal bovine tissue as an in vitro model and found that NCAPG was expressed during myogenic
differentiation in the cytoplasm and nucleus. Silencing NCAPG prolonged the mitosis and impaired the
differentiation due to increased myoblast apoptosis. After 1.5 days of differentiation, silencing NCAPG
enhanced muscle-specific gene expression. An assay for transposase-accessible chromatin- high
throughput sequencing (ATAC-seq) revealed that silencing NCAPG altered chromatin accessibility to
activating protein 1 (AP-1) and its subunits. Knocking down the expression of the AP-1 subunits
fos-related antigen 2 (FOSL2) or junB proto-oncogene (JUNB) enhanced part of the muscle-specific
gene expression. In conclusion, our data provide valuable evidence about NCAPG’s function in
myogenesis, as well as its potential role in gene expression.
Keywords: NCAPG; bovine myoblasts; myogenesis; chromatin accessibility; AP-1
1. Introduction
The growth rate is the most important trait in farm animal production. Genome variations
regulating animal growth and development have been widely studied in farm animals. NCAPG is
a gene well-documented to be associated with body size, average daily gain, feed intake efficiency,
fetal growth, carcass trait, and muscle development in beef cattle [1–7]; body weight in sheep [8]; and
withers height in horses [9,10]. Moreover, in clinical practice, NCAPG is a crucial gene that is correlated
with height [11].
NCAPG is a subunit of the condensin I complex, which is essential for the structural maintenance
of chromosomes [12]. The core subunits of condensin are SMC2 and SMC4, both of which are the
members of structural maintenance of chromosome (SMC) family of chromosomal ATPases [13].
Condensin I also has unique non-SMC subunits: CAP-G, CAP-H, and CAP-D2 [12]. Previous studies
Int. J. Mol. Sci. 2020, 21, 1248; doi:10.3390/ijms21041248 www.mdpi.com/journal/ijms
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have revealed that both condensin members play essential but distinct roles in mitosis. Condensin I is
sequestered in the cytoplasm during the interphase and gains access to chromosomes only after the
nuclear envelope break down (NEBD) in the prometaphase. Condensin II functions in the nucleus from
the interphase through the prophase as an early regulator of chromosome condensation. After NEBD,
condensin I engages in further chromosome compaction to facilitate final mitosis [14–16]. In one study,
the abrogation of the CAP-D2 subunit resulted in a significant delay of prometaphase to anaphase
progression compared to the control group [15]. This provided direct evidence for the relationship
between NCAPG and growth traits.
Skeletal muscle development is one of the most important traits in farm animal production
because skeletal muscle account for about half of an animal’s body weight. Muscle development is
classified into prenatal and postnatal stages. The fetal stage is crucial for skeletal muscle development,
as the number of muscle fibers barely increases after birth [17–19].
However, the regulatory mechanisms and biological functions of NCAPG are still unknown.
In particular, NCAPG’s role in the development of myoblasts in the fetal stage needs exploration.
In this study, the role of NCAPG in the myogenic differentiation of myoblasts derived from fetal bovine
tissue was determined using RNA interference to knock down NCAPG gene expression. Moreover,
due to NCAPG’s conserved roles in other tissues, our study and its meanings may also be applied
elsewhere in the body.
2. Results
2.1. Myogenic Differentiation of Myoblasts Derived from Fetal Bovine Tissue
After 24 h of differentiation, some myotubes could be observed. After 48 h, a majority of the
myoblasts had fused into myotubes. After an additional two days of differentiation, both the size
and length of the myotubes increased (Figure 1A). RNA and proteins were extracted from the cells
on days 0, 2, and 4 to analyze the muscle-specific gene expression profile during proliferation and
differentiation. Myoblast determination protein 1 (MYOD) and myogenic Factor 5 (MYF5) mRNA
expression decreased during proliferation and differentiation, while MYOG expression increased until
day 2 of differentiation, after which it decreased (Figure 1B).
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levels of MYF5, MYOD, MYOG, MYH1, MYH2, MYH3 and MYH4 during proliferation (P) and 
myogenic differentiation (D0, D2, and D4). The results are represented as the mean ± the SEM from 
at least three independent experiments. (C) Western blot evaluating the protein levels of MYOD and 
MHCs in the cultured cells, as described in (B). 
Figure 1. Myogenic differentiation of myoblasts derived from fetal bovine tissue. (A) Microscopic
images of bovine myoblasts on days 0, 2, and 4 of differentiation. Scale bars = 100 µm. (B) Transcript
levels of MYF5, MYOD, YOG, MYH1, MYH2, MYH3 and MYH4 during proliferation (P) and myogenic
differentiation (D0, D2, and D4). The results are represented as the me n ± the SEM from at least three
independent experiments. (C) Western blot evaluating the protein levels of MYOD and MHCs in the
cultured cells, as described in (B).
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As for myosin heavy chain (MYH) isoforms in skeletal muscle, the expression of MYH1, MYH2,
MYH3, and MYH4 was relatively low during proliferation and early differentiation, but it increased
dramatically during late differentiation (Figure 1B). In particular, MYH2 expression increased nearly
200-fold compared to basal level on day 4. Consistently, western bolt analyses showed that MYH
expression increased gradually during the differentiation of myoblasts, while MYOD expression
decreased during differentiation (Figure 1C). From these results, it is clear that the use of myoblasts
derived from fetal tissue is a reliable model for studying early myogenic differentiation in cattle.
2.2. NCAPG Inhibition Prolonged the Prometaphase and Metaphase of the Proliferating Myoblasts
To investigate the role of NCAPG, we first analyzed its expression (as well as that of other subunit
genes of condensin I and II) during proliferation and differentiation. NCAPG was robustly expressed
during proliferation and the beginning of differentiation. The mRNA condensin core subunits SMC2
and SMC4 had similar expression patterns, as did the non-SMC regulatory subunits NCAPG, NCAPH,
NCAPD2, NCAPG2, NCAPH2, and NCAPD3. These genes had robust expression during proliferation,
but then the mRNA level attenuated until day 2. After day 2 of differentiation, their expression
increased slightly (Figure S1).
The regulatory mechanism of NCAPG in mitosis has previously been studied in rodent cells.
To explore its function in bovine myoblasts, we designed three siRNAs targeting common exons of
NCAPG transcript isoforms to knock down total NCAPG mRNA. Here, siRNA003 was selected for the
knockdown experiments due to its high efficiency (Figure 2A). We first identified a morphological
change in the myoblasts in the knowndown (KD) group, which appeared as a flattened stellate shape
(Figure 2B).
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Figure 2. NCAPG KD elongated the prometaph d metaphase. (A) The silencing efficiency of
NCAPG siRNA . We design d three siRNAs tha were transfected into l sts, and the mRNA level
was measured to determine the siRNA efficiency. The results are represented as the mean ± the SEM
(three biological replicates), ** p < 0.01. (B) Cell morphology of NCAPG silencing myoblasts. NCAPG
was depleted in the proliferating myoblasts. Scale bar = 100 µm. (C) An analysis of chromosome
condensation during the prophase in live myoblasts depleted of NCAPG. To visualize chromatin,
we stably expressed H2B–EGFP in th myobla ts. Prophase image s quen es were extracted from
long-term imaging experiments and alig ed long a time axis according to nuclear envelope breakdown
(NEBD). Imaging was done 48–72 h after siRNA transfection. Bar = 5 µm. (D) The time duration of the
prometaphase and metaphase in the myoblasts. The time from NEBD to the onset of the anaphase was
measured using at least six replicates, ** p < 0.01.
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To confirm NCAPG’s role in bovine myoblast mitosis, we employed a lentivirus to express the fused
bH2B–EGFP gene while knocking down NCAPG mRNA expression. About one day after the lentivirus
infection, green fluorescent protein (GFP) expression was clustered in the nucleus. Then, the myoblasts
were subcultured at a low density and transfected with siRNA. In order to observe the mitotic process,
pictures were taken every 3 min during proliferation for two days after siRNA transfection (Figure 2C).
The time between NEBD and the onset of the anaphase was determined. The siRNA control (NC)
group required about 19.5 ± 4.1 min from NEBD to initiate of anaphase, whereas the siRNA group
took about 25.8 ± 5.0 min (Figure 2D). Therefore, we found that the knockdown of NCAPG prolonged
the procession of myoblast mitosis.
2.3. NCAPG Inhibition Impaired Myogenic Differentiation in Myoblasts
Until this study, the role of NCAPG in myogenic differentiation had not been explored. Intriguingly,
during differentiation, both the mRNA and protein expression of NCAPG were relatively low compared
to during proliferation (Figure 1C and Figure S1). First, we detected NCAPG localization in the
myoblasts. The immunofluorescence (IF) results showed that NCAPG could be detected in both the
nucleus and cytoplasm of the myoblasts on day 2 of differentiation (Figure S2A). Subsequently, in order
to explore the distribution of NCAPG in the myoblasts, we analyzed its presence in the cytoplasm
and nucleus (separately). Here, β-tubulin and H2B were used as a reference for cytoplasm proteins
and nuclear proteins, respectively. The immunostaining results showed that NCAPG was localized in
both the cytoplasm and nucleus (Figure S2B). This nuclear localization made it possible for NCAPG to
access chromatin. This suggests that NCAPG took part in regulating myogenic differentiation.
To investigate the role of NCAPG in myogenic differentiation, we interfered with its expression by
transfecting siRNA003, while scrambled siRNA used as a control. Myotubes appeared around 48 h
after differentiation. About four days after the induction of myogenesis, we could observe obvious
myotubes in the NC group, whereas KD caused dysfunctional fusion (Figure 3A). Then, an IF test
was done using an MYH antibody to identify the myotubes, and a similar difference was observed
(Figure 3B). To further explore the alteration in gene expression, we extracted RNA and proteins from
the myoblasts four days after NCAPG knockdown. NCAPG expression had decreased by about 70% by
day 4. We detected the expression of some muscle-specific genes. For instance, MYH1, MYH2, MYH3,
MYH4, MYOD, and MYOG expression was significantly decreased in the KD group (p < 0.01, Figure 3C).
However, a difference in MYF5 expression between the two groups was not detected (Figure 3C).
Immunostaining showed similar results: the protein levels of MYHs and NCAPG decreased after
NCAPG knockdown (Figure 3D).
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2.4. NCAPG KD Facilitated Apoptosis
To explore the mech nism of NCAPG in impairing myogenesis, we detected apoptosis on day 4
using a TdT-mediated dUTP nick-end labeling (TUNEL) assay and a caspase 3 activity assay. As shown
in Figure 4A, NCAPG knockdown increased the number of TUNEL-positive cells on day 4. About 23%
of cells in the siRNA group were TUNEL-positive, while the apoptosis rate of the NC group was less
than 1% (Figure 4B). The caspase 3 activity assay showed that NCAPG knockdown led to a three-fold
increase in caspase-3 activity compared to the NC group (Figure 4C).
Int. J. Mol. Sci. 2020, 21, 1248 5 of 15 
 
 
Figure 3. Silencing NCAPG impaired the differentiation of myoblasts. (A) Cell morphology of 
NCAPG-silenced myoblasts on day 4 of differentiation. Scale bar = 100 µm. (B) NCAPG-silenced 
myobl sts on day 4 of differentiation. Myotub s were visualized using IF staini g with MYH 
antibodies. Scale bar = 100 µm. (C) Transcript levels of muscle-specific genes on day 4 of 
differentiation. The results are presented as the mean ± the SEM from at least three independent 
experiments: ** p < 0.01. (D) Western blot evaluating the protein levels of NCAPG and MHCs in 
myoblasts on day 4 of differentiation. 
2.4. NCAPG KD Facilitated Apoptosis 
To explore the mechanism of NCAPG in impairing myogenesis, we detected apoptosis on day 4 
using a TdT-med ated dUTP nick-end labeling (TUNEL) assay and a c spase 3 activity assay. As 
shown in Figure 4A, NCAPG knockdown increased the number of TUNEL-positive cells on day 4. 
Abou  23% f cells in the siRNA group were TUNEL-p sitive, while the apoptosis rate of the NC 
roup was less than 1% (Figure 4B). The caspase 3 activity assay showed that NCAPG knockdown 
led to a three-fold increase in caspase-3 activity compared to the NC group (Figure 4C). 
 
Figure 4. NCAPG KD induced apoptosis. (A) Transcript levels of muscle-specific gene expression in
AP-1 subunits (FOSL2) in depleted myoblasts. (B,C) Transcript levels of muscle-specific gene expression
in AP-1 subunits (JUNB) in depleted myoblasts. The results are presented as the mean ± the SEM from
at least three independent experiments, * p < 0.05, ** p < 0.01.
Int. J. Mol. Sci. 2020, 21, 1248 6 of 15
2.5. Myogenic Gene Expression was Boosted on Day 1.5 of Differentiation after NCAPG Knockdown
Interestingly, despite the reduced myogenesis in the NCAPG knockdown myoblasts after four
days of myogenesis, we found that the myotube formation of the siRNA group was slightly higher than
that of the NC group at 1.5–2 days of myogenesis (Figure 5A). At 36 h, we analyzed the muscle-specific
gene expression as well as the condensin subunit genes. The results showed that in the siRNA group,
the mRNA levels of MYH1, MYH2, MYH3, MYH4, MYF5, and MYOG were significantly higher than
in the NC group. There was no difference in the expression of MYOD between groups (Figure 5B).
Consistently, the protein expression analysis showed that the expression of MYHs and MYOG in the
siRNA group was upregulated, while MYOD was not affected (Figure 5C).
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2.6. NCAPG Knockdown Altered Chromatin Compaction and Accessibility
To investigate the relationship between altered gene expression and NCAPG knockdown, we
conducted an IF test using H4K20me1 and H4K16ac antibodies. H4K20me1 modification is positively
correlated with chromatin compaction, while H4K16ac is negatively correlated with chromatin
compaction [20,21]. The results showed that the fluorescence intensity of H4K20me1 in the siRNA
group attenuated significantly, while that of H4K16ac increased significantly after knockdown on day
1.5 (Figure 6A,B). These results demonstrated that NCAPG knockdown reduced chromatin compaction.
To further study chromatin compaction after NCAPG knockdown, we used an ATAC-seq to isolate
the accessible chromatin on day 1.5. The sequencing reads were mapped to the bovine genome, and
summarized statistics of the read mapping are listed in Table S1. The reads from both the NC and
si-NCAPG groups were enriched around transcription start sites (TSS) (Figure 6C), and the peaks
were called using MACS2. The peak number from the NC group was around 110,000, while the peak
number from the si-NCAPG group varied between 71,000 and 75,000 (Table S2). The annotation of
peaks revealed that silencing NCAPG resulted in the proportion of the peaks located in −1000 bp
Int. J. Mol. Sci. 2020, 21, 1248 7 of 15
(Figure S3). However, compared to NC, silencing NCAPG led to more of a decrease in the accessibility
of chromatin sites (Figure 6D). Pearson correlation coefficients between the NC and si-NCAPG groups
were calculated based on the Log10 RPM matrix (Figure S4). A Gene Ontology analysis revealed that
silencing NCAPG affected multiple processes, including development, cell differentiation, and the
positive regulation of biological processes (Figure S5). The Kyoto Encyclopedia of Genes and Genomes
(KEGG) analysis also revealed the pathways regulated by NCAPG, including the metabolic pathway,
the MAPK pathway, the regulation of actin cytoskeleton pathway, and the calcium signaling pathway
(Figure S5). The metabolic pathway had the highest proportion of genes with altered accessibility,
including PRKAA1 and SIRT1 (Figure S6). The 10 most enriched motifs are listed in Figure 6E.
A motif analysis revealed that silencing NCAPG induced the decreased accessibility of chromatin
fragments containing transcription factors (TF) binding sites such as AP-1 subunits (JUNB, FOSL2,
and FOSL1), CCCTC-binding factor (CTCF), and basic leucine zipper ATF-Like transcription factor
(BATF) (Figure 6E).
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Figure 6. NCAPG n ckdown altered chromatin c mpaction and accessibility. (A,B) (Left)
Represen ative immun fluorescence images of myoblasts transfected with a negative control or
si-NCAPG and stained with antibodie against H4K20me1 (green) or H4K16ac (red). DNA (DAPI)
is shown in blue. Scale bars = 10 µm. (Right) Fluorescence intensity quantification. The results are
presented as the mean± the SEM, * p < 0.05, ** p < 0.01. (C) (top) A histogram of the intensity of enriched
reads (from TSS −3 kb to TES +3 kb) for each replicate. (bottom) A heatmap of ATAC-seq signal
mapping with annotated TSS. (D) Scatterplots showing changes in chromatin accessibility between the
NC and si-NCAPG groups. (E) TF motifs identified from ATAC-seq peaks. (F) (Left) Transcript levels
of muscle-specific gene expression in AP-1 subunits (FOSL2) in depleted myoblasts. (Right) Transcript
levels of muscle-specific gene expression in AP-1 subunits (JUNB) in depleted myoblasts. The results
are presented as the mean ± the SEM from at least three independent experiments, * p < 0.05, ** p < 0.01.
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To analyze the relationship between AP-1 binding and muscle-specific gene expression, we knocked
down the AP-1 subunit genes FOSL2 and JUNB using siRNA. FOSL2 silencing increased the expression
of MYOD, MYOG, MYH2, and MYH4, while JUNB silencing improved the expression of MYOD, MYH1,
MYH2, and MYH4 but repressed MYH3 expression (Figure 6F).
3. Discussion
The location of condensins in the cytoplasm and their role in mitosis have been intensively
investigated [14–16]. Condensin II primarily contributes to the axial shortening of chromatids, while
condensin I has a role in lateral compaction [22]. In one study, depletion of the condensin I subunit
prolonged prometaphase-to-anaphase progression by more than 150% [15]. In our study, we found
a similar delay after silencing NCAPG. However, prometaphase-to-anaphase progress was delayed
by about 32% compared to the control group. The difference may have been due to the cell type,
the siRNA concentration and efficiency, and the condensin subunit selected.
The common view of condensin localization is that condensin I is cytoplasmic during the interphase
and, after the prophase and NEBD, has access to chromatin [15,23]. However, recent reports have
indicated that a small amount of condensin I can be found in the nucleus during the G1 phase, which is
gradually lost during the S and G2 phases [24]. In those reports, silencing the subunits of condensin I
in the G0/G1-phase cells resulted in gene misregulation [24,25]. In our study, all condensin subunits,
including NCAPG, decreased dramatically after the initiation of myogenic differentiation and remained
at a relatively low level late in the differentiation process. We also found NCAPG expressed in the
nuclei of differentiating myogenic myoblast cells. This implies that condensin I may function not only
during mitosis, but also during other stages of the cell cycle.
We found that knocking down NCAPG during the myogenic differentiation of fetal bovine
muscle myoblasts promoted apoptosis. The association between apoptosis and NCAPG or condensin
I depletion has been reported in several studies. In zebrafish, a mutation in NCAPG resulted in
increased genomic imbalances and in an increased rate of apoptosis in the retina [26]. In another work,
silencing NCAPG in hepatocellular carcinoma cells inhibited proliferation and induced apoptosis [27,28].
Condensin I disruption has also led to apoptosis in the germline [29]. Further, knocking down NCAPD2,
a subunit of condensin I, has led to apoptosis in triple-negative breast cancer cells [30].
In contrast to its established role in chromatin condensation in mitosis, our knowledge about
condensin I in regulating gene expression is still limited. Condensin I is largely absent from
heterochromatic regions and binds predominantly to promoter sequences of active genes in mitotic
chicken DT40 cells [31]. In human cell mitosis, TATA-binding protein (TBP) transmits active gene
memory to daughter cells by directly interacting with NCAPG in the vicinity of these promoters via its
associated protein phosphatase 2A (PP2A), thereby inhibiting the compaction of these regions [32].
In Drosophila melanogaster, condensin I has been implicated in the repression of homeotic genes [33].
In yeast, Hocquet et al. have reported that condensins play no direct role in the maintenance of the
transcriptome either during interphase or during mitosis: in that study, the gene expression changes
in postmitotic fission yeast cells were largely a consequence of chromosome mis-segregation during
the anaphase [34]. Condensin depletion causes genome decompaction without altering the level of
global gene expression in saccharomyces cerevisiae [35]. In one study, condensin II physically interacted
with TFIIIC, and they both colocalized at active gene promoters (in mouse and human genomes): this
was facilitated by the interaction between NCAPD3 and the epigenetic mark H3K4me3 [36]. Thus
far, previous studies have not provided conclusive evidence showing how condensin I regulates gene
expression. In our study, chromatin condensation decreased after NCAPG silencing. We also found
that muscle-specific genes were first upregulated after the silencing of NCAPG, but then they decreased.
Because accessibility is related to chromatin condensation [37] and histone acetylation [38], we suspect
that NCAPG might affect chromatin accessibility.
Using an ATAC-seq and motif analysis, we found that AP-1 enrichment (and that of its subunits)
at accessible chromatin regions decreased after NCAPG silencing. AP-1 transcription is a dimeric
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complex involved in diverse cellular processes such as proliferation, differentiation, and apoptosis [39].
This dimeric complex is composed of Jun (c-Jun, JunB, and JunD) and Fos (c-Fos, FosB, Fra-1, and Fra-2)
proto-oncogene proteins that bind to a cis-element called the TRE (12-O-tetradecanoylphorbol-13-acetate
response element) [39]. Different AP-1 dimer combinations are crucial for AP-1 binding activities
and their biological function [40–42]. In one study of skeletal muscle cells, AP-1 binding sites were
also enriched in a large subset of MyoD-regulated genes, many of which were downregulated during
differentiation [43]. During myogenic differentiation, Fra-2 is a major component of the AP-1 complex
in differentiating cells [44]. For instance, silencing Fra-2 increases the protein expression of terminal
differentiation markers such as muscle creatine kinase (MCK) and MYHC [45]. Previous research has
reported that c-Jun can inhibit differentiation by directly binding to MYOD [46]. MYOD can act as
a negative regulator in c-fos transcription by binding with serum-responsive elements in the c-fos
promoter [47]. JunB is also involved in the early steps of the inhibition of myogenic differentiation.
An increase in JunB mRNA expression is highly correlated with AP-1 binding activities and inhibits
the expression of myoblast differentiation markers in C2C12 cells [48]. Here, we used siRNA to silence
the AP-1 subunits JunB and Fra-2 and found increased expression in most muscle-specific genes.
In conclusion, NCAPG is indispensable in myogenic differentiation, and the lack of NCAPG
induces apoptosis. NCAPG also regulates chromatin accessibility to AP-1, a ubiquitously expressed TF
complex, and subsequently affects gene expression. These results provide new evidence for NCAPG’s
function in myogenesis, as well as its potential role in gene expression.
4. Materials and Methods
4.1. Ethics Statement
The animal experiments were performed according to the guidelines established by the Regulations
for the Administration of Affairs Concerning Experimental Animals (Ministry of Science and Technology,
China, 2004). All animal experimental protocols in this study were carried out in strict conformance
with the rules of the Animal Ethics Committee of the Institute of Animal Sciences, Chinese Academy of
Agricultural Sciences (No. IAS2019-48; 12/9/2019). Pregnant cows were raised by the Inner Mongolia
Aokesi Agriculture Co., Ltd. (Wulagai, China). All efforts were made to minimize the cows’ suffering.
4.2. Primary Cell Isolation and Cell Culture
The myoblast cells were enzymatically isolated from longissimus dorsi tissues obtained from
bovine fetuses 90 to 120 days old, as described previously [49]. At 70%–80% confluence, the cells were
passaged with 0.25% trypsin-EDTA (Gibco, Grand Island, NY, USA). After reaching 100% confluence,
cells were induced in differentiation medium (DM) consisting of DMEM containing 5% horse serum
(Gibco). The medium was exchanged every 2 days.
4.3. siRNA Transfection and Gene Knockdown
The transfection of siRNA into myoblast cells was performed using Lipofectamine™ RNAiMAX
transfection reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) when the cells reached
100% confluence.
Small interfering RNA (siRNA) was obtained from RiboBio (Guangzhou, China), and the
sequences are shown in Table S3: siRNA transfection was performed by following the manufacturer′s
recommended procedure. Cells were transfected with siRNA against NCAPG (siNCAPG) or siRNA
control (NC) at a final concentration of 50 nM.
4.4. RNA Extraction, cDNA Synthesis, and Quantitative Real-Time PCR
Total RNA was extracted from cells using TRIzol reagent (Invitrogen Life Technologies). RNA
concentration and quality were assessed by a NanoPhotometer N50 (Implen, Munich, Germany) and
1.5% agarose gel electrophoresis. A cDNA synthesis for mRNA was performed using PrimeScript RT
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Master Mix (Perfect Real Time) (TaKaRa, Kusatsu, Japan). In addition, qRT-PCR was performed on a
QuantStudio 7 Flex Real-Time PCR System (Life, Carlsbad, CA, USA) with a KAPA SYBR® FAST qPCR
Kit (KAPABiosystems, Wilmington, MA, USA). Samples from at least three independent experiments
were assayed following the manufacturer′s instructions. The sequence of qRT-PCR detection primers
can be found in CS4.
4.5. Immunofluorescence
The immunofluorescence tests were performed in myoblast cells cultured in 12-well plates. Cells
were fixed in 4% paraformaldehyde for 15 min and then washed three times with phosphate-buffered
saline (PBS). Subsequently, cells were incubated in 0.1% Triton X-100 diluted by PBS for 10 min at
room temperature, and the cells were blocked with 1% albumin bovine serum (Beyotime, Shanghai,
China) for 30 min in order to reduce the nonspecific binding of primary antibodies. After incubation
with the primary antibodies overnight at 4 ◦C, secondary antibodies were added, and the cells were
incubated at room temperature for 1 h. The cell nuclei were stained with 4′,6-diamidino-2-phenylindole
(DAPI) (Sigma-Aldrich, St. Louis, MO, USA) for 5 min, and images were obtained with a confocal
microscope (TCS SP8, Leica, Wetzlar, Germany). The following antibodies were used: MHC antibody
(MF20, Developmental Studies Hybridoma Bank, Iowa, USA, 1:100); NCAPG (sc-101014, Santa Cruz,
Delaware Ave Santa Cruz, CA, USA, 1:1000); NCAPD3 (16828-1-AP, Proteintech, Chicago, IL, USA,
1:500); H4K20me1 (ab9051, Abcam, Cambridge, UK, 1:1000); and H4K16ac (13534, Cell Signaling
Technology, Danvers, MA, USA, 1:1600).
4.6. Western Blot
Cells were digested with low-concentration trypsin and collected into tubes. We used a Nuclear
and Cytoplasm Protein Extraction Kit (Beyotime) to separate nuclear and cytoplasm proteins. Cells
were lysed in an ice cold radio immunoprecipitation assay (RIPA) lysis buffer with 1 mM phenylmethyl
sulfonyl fluoride (Sigma-Aldrich), which was used for cell protein extraction. Protein concentration
was determined using a BCA KIT (Beyotime). Proteins were separated by 4%–12% SurePAGE gels
(GenScript, Nanjing, China), transferred to a nitrocellulose membrane (Pall, Mexico), and then detected
using antibodies according to standard procedures. Primary antibodies were applied overnight at
4 ◦C for western blot tests, and their dilutions were as follows: NCAPG (sc-101014, Santa Cruz,
1:1000); MYHC (MF20, Developmental Studies Hybridoma Bank, 1:50); MYOD (sc-377460, Santa Cruz,
1:1000); MYOG (sc-12732, Santa Cruz, 1:1000) and β-tubulin (10094-1-AP, Proteintech, 1:2000). Finally,
secondary antibodies were visualized with HRP-conjugated secondary antibodies that were applied
for 1 h at room temperature. ECL western blotting detection reagent (Beyotime) was used to visualize
the protein bands.
4.7. Lentivirus Infection
Cells were seeded in 3.5-cm culture dishes (Corning, Corning, NY, USA) with a 40%~50%
confluence. A lentivirus expressing GFP and H2B was purchased from HanBio (Shanghai, China;
www.hanbio.net). The lentivirus-coated GFP–H2B was transfected into cells with polybrene (HanBio).
After 48 h of infection at 37 ◦C, the medium was replaced by fresh DMEM. The mitosis process was
observed with a confocal microscope (TCS SP8, Leica, Wetzlar, Germany) at day 1.5.
4.8. TUNEL Staining
The apoptosis of myoblasts was examined using a TUNEL assay (Beyotime). The TUNEL assay
was performed in accordance with the manufacturer’s protocols. TUNEL-positive cells (indicated
by red fluorescent staining) were defined as having undergone apoptotic cell death. In terms of cell
counts, TUNEL-positive cells were counted in three random fields of each section. The apoptosis index
was calculated according to the following formula: the number of apoptotic cells/the total number of
nucleated cells × 100%.
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4.9. Caspase-3 Activity Detection
Caspase-3 activity was measured spectrophotometrically via the detection of pNA cleavage
by caspase-3-specific substrates. These experiments were completed using a Caspase-3 Assay Kit
(Beyotime). After the cell lysates were incubated with Ac-DEVD-pNA for 2 h at 37 ◦C, the samples
were read at 405 nm.
4.10. ATAC-Seq and Data Analysis
The ATAC-seq libraries were constructed with a TruePrep DNA Library Prep Kit V2 for Illumina
(Vazyme, Nanjing, China). Briefly, 50,000 collected cells (counted using trypan blue exclusion) were
lysed in cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP40, 0.1%
Tween-20, and 0.01% Digitalis saponin) for 10 min on ice. After centrifugation at 500 g for 5 min, the
nuclei were pelleted and resuspended in Transposase buffer. The transposition reaction was carried
out for 30 min at 37 ◦C. Following purification, the libraries were amplified for 16 cycles and purified
using VAHTS RNA Clean Beads (Vazyme). Libraries were quantitated using a Qubit 4 Fluorometer
(Invitrogen, Singapore). Quality control of the libraries was performed with a Bioanalyzer 2100 (Agilent
Technologies, Santa Clara, CA, USA, D1000 screentapes and reagents, 5067-5582). ATAC libraries
were sequenced and multiplexed on an Illumina HiSeq X Ten with 150-bp paired ends. Raw sequence
reads were initially processed for quality control by a FastQC (0.11.5), and then a Skewer (0.2.2) was
used to remove the adapter sequences and poor-quality reads. Subsequently, the remaining reads
were mapped onto the bovine reference genome of ARS-UCD1.2 using Burrows–Wheeler Alignment
(BWA) (0.7.12). SAM files were converted into a BAM format using Samtools and were used for peak
calling. A consensus map was created for each group by merging all samples using the BEDTools
merge command. MACS2 (2.1.2) was used to call peaks. Correlations between libraries were calculated
using the deepTools (3.0.2) bamCorrelate bins command. ATAC-seq peaks were annotated using a
PeakAnnotator. A TF-binding motif analysis of ATAC-seq data was performed using HOMER (v4.9.1).
Only known motifs from HOMER’s motif database were considered. We studied the motifs enriched
by ATAC-seq peaks using findMotifsGenome.pl. A GO enrichment analysis of differential peaks was
performed using the Goseq R package. GOseq was applied to assess enrichment, and topGO was
used for plot directed acyclic graph bases of significantly enriched genes. We used KOBAS software
(3.0) to determine whether differential peaks were significantly enriched in KEGG pathways. A motif
enrichment analysis was performed with the findMotifsGenome.pl command in the HOMER package
(4.9.1). The raw sequence data reported in this paper have been deposited in the Genome Sequence
Archive (Genomics, Proteomics & Bioinformatics 2017) at the BIG Data Center (Nucleic Acids Res
2019), Beijing Institute of Genomics (BIG), Chinese Academy of Sciences, under accession numbers
CRA002306 and CRA002306. They are publicly accessible at https://bigd.big.ac.cn/gsa.
4.11. Statistical Analyses
All data are presented as the mean ± the SEM from at least three independent experiments for each
treatment. Data were analyzed using Student’s t-test and incorporated into GraphPad Prism version 6.0
software (GraphPad Inc., San Diego, CA, USA). p < 0.05 was considered to be statistically significant.
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Abbreviations
NCAPG Non-SMC condensin I complex subunit G
SMC Structural maintenance of chromosomes
CAP-G Chromosome-associated protein G
CAP-H Non-SMC condensin I complex subunit H
CAP-D2 Non-SMC condensin I complex subunit D2
MYH Myosin heavy chain
MYOG Myogenin
MYOD Myoblast determination protein 1
MYF5 Myogenic Factor 5
NEBD Nuclear envelope breakdown
H2B Histone H2B-like
IF Immunofluorescence
KD Knockdown
GFP Green fluorescent protein
TUNEL TdT-mediated dUTP nick-end labeling
H4K20me1 Histone 4 lysine 20 monomethylation
H4K16ac Acetylation of histone H4 on lysine 16
H3K4me3 Histone H3 trimethylated at lysine 4
TSS Transcription start site
KEGG Kyoto Encyclopedia of Genes and Genomes
MAPK Mitogen-activated protein kinase
NC Negative control
MCK Muscle creatine kinase
siRNA Small interfering RNAs
ATAC- Assay for Transposase-Accessible Chromatin
seq High-throughput sequencing
TSS Transcription start sites
AP-1 Activating protein 1
c-Jun Transcription factor AP-1-like
JUNB JunB proto-oncogene
JUND JunD proto-oncogene
FOSL2 Fos-related antigen 2
FOSL1 Fos-related antigen 1
PRKAA1 Protein kinase AMP-activated catalytic subunit alpha 1
SIRT1 Sirtuin 1
CTCF CCCTC-Binding Factor
BATF Basic Leucine Zipper ATF-Like Transcription Factor
TBP TATA-binding protein
PP2A Protein phosphatase 2A
DAPI 4′,6-diamidino-2-phenylindole
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